Mineralys Therapeutics (MLYS) Amortizatization of Intangibles (2022 - 2026)

Mineralys Therapeutics has reported Amortizatization of Intangibles for 5 years, with the latest figure at $4.6 million in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 342.16% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (up 69.45% YoY) and the FY2025 annual result came in at $9.9 million, up 5.04% from the prior year.
• Amortizatization of Intangibles improved to $4.6 million in Q1 2026 per MLYS's latest filing, from $4.2 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $4.6 million in Q1 2026 and troughed at $239000.0 in Q3 2022.
• A 5-year average of $2.1 million and a median of $2.1 million in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles jumped 720.92% in 2023, then plunged 58.31% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $410000.0 in 2022, then jumped by 403.9% to $2.1 million in 2023, then tumbled by 35.29% to $1.3 million in 2024, then soared by 214.73% to $4.2 million in 2025, then gained by 9.91% to $4.6 million in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $4.6 million, $4.2 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.